Wealthy nations may be reaching a life expectancy limit — at least for now, study shows

Also: With boost from RFK Jr. and Tucker Carlson, two chronic disease entrepreneurs vault into Trump's orbit

October 7, 2024 Check out STAT+

Sponsored By

JONATHAN NACKSTRAND/AFP via Getty Images 2024 Nobel prize in medicine: Ruvkun, Ambros win for discovery of microRNA The prize went to the two researchers for their discovery of microRNA, which plays a crucial role in regulating gene activity. By Andrew Joseph Wealthy nations might be reaching a life expectancy limit, study suggests — at least for now 'Reality check' on extreme human longevity. Life expectancy increased due to vaccines, antibiotics, medicine — how to slow aging still unknown By Jonathan Wosen Sammy Basso, progeria advocate, has died at 28 The oldest known survivor of progeria, his life was utterly unlike others', but he lived with the conviction he could connect with anybody. By Eric Boodman Hyacinth Empinado/STAT STAT+ | 12 people changing the course of the Chinese biopharma industry STAT profile series on key players in life sciences looks at the 12 top players in Chinese biotechnology, from researchers to pharma corporate executives. By Brian Yang STAT+ | Scholar Rock drug for spinal muscular atrophy succeeds in late-stage study In a year-long Phase 3 trial, the company tested the drug, called apitegromab, on top of existing treatments for the disease. By Elaine Chen STAT+ | Janet Woodcock, former FDA official, joins board of patient group focused on 'rediscovering' old drugs Every Cure, led by physician David Fajgenbaum, is scouring thousands of existing drugs to see if any can cure hard-to-treat diseases. By Matthew Herper Illustration: Anna Yeo/STAT; Photos: Emrich, Getty, AP STAT+ | With boost from RFK Jr. and Tucker Carlson, two chronic disease entrepreneurs vault into Trump's orbit The chronic disease entrepreneurs, noticed by Tucker Carlson, Joe Rogan, and RFK Jr., are offering health policy advice to Donald Trump. By Isabella Cueto

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser